Southwest Prostate Cancer Symposium™ 2018 Slides

To view presentation slides, click on the links below.

Thursday, April 12, 2018

1:00 PM – 6:00 PM SESSION I: Video Demonstrations/Biopsy Techniques
Moderator: Neil E. Fleshner, MD, MPH, FRCSC
1:10 PM – 1:40 PM Transrectal Fusion Biopsy Eigen/Artemis ™ Technique
Laurence Klotz, MD, FRCSC
1:40 PM – 2:10 PM Transrectal Fusion Biopsy UroNav Technique
Peter A. Pinto, MD
2:10 PM – 2:40 PM NOT AVAILABLE
3DBiopsy™ Transperineal Mapping Biopsy
Nelson N. Stone, MD
2:40 PM – 3:10 PM NOT AVAILABLE
Permanent Prostate Brachytherapy
Richard G. Stock, MD
3:10 PM – 3:40 PM HIFU: Whole Gland and Focal Therapy
Neil E. Fleshner, MD, MPH, FRCSC
3:40 PM – 4:00 PM Androgen Deprivation and the Metabolic Syndrome
Neil E. Fleshner, MD, MPH, FRCSC
4:00 PM – 4:30 PM Break and Visit Exhibits
4:30 PM – 5:00 PM NOT AVAILABLE
Cryotherapy
John F. Ward, MD, FACS
5:00 PM – 5:30 PM NOT AVAILABLE
Mapping Biopsy and Focal Cryotherapy
Nelson N. Stone, MD

Friday, April 13, 2018

8:00 AM – 12:30 PM SESSION II: Initial Diagnosis and Active Surveillance
Moderator: Laurence Klotz, MD, FRCSC
8:00 AM – 8:25 AM Changing Distribution, Size and Grade of Prostate Cancer: Whole Mount Prostatectomy Analysis
M. Scott Lucia, MD
8:25 AM – 8:50 AM Active Surveillance—From Bench to Bedside
Laurence Klotz, MD, FRCSC
8:50 AM – 9:40 AM Should MRI Be Used to Monitor for AS?
Pro: Peter A. Pinto, MD
Con: Nelson N. Stone, MD
9:40 AM – 10:15 AM Prostate Biopsy: Techniques, Concerns, and Precautions
Gerald L. Andriole, Jr., MD
10:40 AM – 11:00 AM Should Testosterone Levels Influence Decision to Biopsy?
Mohit Khera, MD, MBA, MPH
11:00 AM – 11:20 AM Update on Prostatectomy Versus Observation Trials
Gerald L. Andriole, Jr., MD

Saturday, April 14, 2018

8:00 AM – 10:30 AM SESSION III: Focal and Hormonal Therapy
Moderator: John F. Ward, MD, FACS
8:00 AM – 8:30 AM Mapping Pathology as a Guide to Focal Therapy: The Role of Mapping Biopsies and Tissue Markers
M. Scott Lucia, MD
8:30 AM – 8:50 AM Focal Cryotherapy
John F. Ward, MD, FACS
8:50 AM – 9:10 AM Focal Brachytherapy
Juanita M. Crook, MD, FRCPC
9:10 AM – 9:30 AM Minimizing Morbidity and Maximizing Outcomes with ADT
Laurence Klotz, MD, FRCSC
9:30 AM – 9:50 AM Testosterone Replacement and Focal Therapy
Mohit Khera, MD, MBA, MPH
9:50 AM – 10:30 AM Panel Discussion
11:00 AM – 1:30 PM  SESSION IV: Definitive Therapy
Moderator: Seth R.Blacksburg, MD, MBA
11:00 AM – 11:20 AM Hypofractionation
Seth R. Blacksburg, MD, MBA
11:20 AM – 11:40 PM Prostatectomy: AS, USPST – What is the Future?
John F. Ward, MD, FACS
11:40 PM – 12:00 PM Long-Term Outcomes of Permanent Brachytherapy
Richard G. Stock, MD
12:00 PM – 12:20 PM Long-Term Outcomes of HDR
Juanita M. Crook, MD, FRCPC
12:20 PM – 12:40 PM How Does Radiobiology Guide Dose, Fraction, and Source Selection?
Seth R. Blacksburg, MD, MBA
12:40 PM – 1:00 PM Preserving Erectile Function After Radiation and Surgery
Mohit Khera, MD, MBA, MPH

Sunday, April 15, 2018

7:00 AM – 12:00 PM Exhibits Open
7:00 AM – 8:00 AM Continental Breakfast
8:00 AM – 10:00 AM SESSION V: Advanced Disease
Moderator: Daniel P. Petrylak, MD
8:00 AM – 8:30 AM Determining Patterns of Failure: Advanced Imaging
Richard G. Stock, MD
8:30 AM – 9:00 AM Early Chemotherapy with Advanced Disease
Daniel P. Petrylak, MD
9:00 AM – 9:30 AM Adjuvant or Salvage RT Post-Radical Prostatectomy
Seth R. Blacksburg, MD, MBA
9:30 AM – 10:00 AM Sequencing of Adjuvant Therapies
Daniel P. Petrylak, MD
10:00 AM – 12:00 PM SESSION VI: Quality of Life and Men’s Health
Moderator: Nelson N. Stone, MD
10:00 AM – 10:20 AM Does RT Favor RP in Long-Term QOL?
Juanita M. Crook, MD, FRCPC
10:20 AM – 10:50 AM Long-Term Erectile Dysfunction and Urinary Morbidity Following Brachytherapy
Nelson N. Stone, MD
10:50 AM – 11:20 PM Prevention and Management of Rectal Toxicity
Richard G. Stock, MD
11:20 AM – 12:00 PM Panel and Case Management
12:00 PM Meeting Adjourn